Cardiology
Endocrinology
Dermatology
Gastroenterology
Geriatrics
Psychiatry
Pulmonology
Rheumatology
Dermatology
FDA Approves Dupilumab for Pediatric Eczema
May 26, 2020
Biologics Do Not Increase Melanoma Risk in Patients With Inflammatory Disease
May 20, 2020
Top-Line Results Positive for New Plaque Psoriasis Treatment
May 08, 2020
Psoriasis Patients with Mental Illness Report Worse Clinical Interaction
May 06, 2020
How COVID-19 Affects Dermatology
May 05, 2020
Dupilumab, Cyclosporine Better Competitors for Atopic Dermatitis Clearance
May 03, 2020
Ixekizumab Continues to Build Chronic Care Portfolio
April 14, 2020
Risankizumab Benefits Chronic Plaque Psoriasis at 2 Years
April 08, 2020
Add-On Dupilumab Significantly Clears Pediatric Eczema Skin
April 05, 2020
AAD House Call: ARQ-151 for Chronic Plaque Psoriasis
March 21, 2020
+ Load More
Copyright® ConsultantLive 2019 Intellisphere, LLC. All Rights Reserved.
